Cytosorbents Corporation (CTSO) - News Archive

CytoSorbents Rights Offering Begins: Implications for ShareholdersIn a significant development for investors, CytoSorbents Corporation has announced the commencement of its rights offering, a strategic initiative aimed...

In a pivotal move aimed at reinvigorating investor confidence and potentially stabilizing its fluctuating market performance, CytoSorbents Corporation has announced an exclusive rights offering for its existing stockhol...

CytoSorbents Corporation, a critical care immunotherapy company specialising in blood purification technology, has recently taken a significant step forward in its global expansion efforts. The company announced the sub...

: This article provides a analysis of recent developments related to CytoSorbents Corporation s new product, DrugSorb-ATR, designed to mitigate bleeding risks in heart bypass surgery patients on ticagrelor. This novel t...

The CytoSorbents Corporation, a renowned player in the field of blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery, has recently made an important announce...

Advancements in Healthcare and Digital Media: The Strategic Moves of CytoSorbents and ZoomerMediaIn a rapidly evolving landscape of healthcare and digital media, two companies have made significant strides: CytoSorbents...

In an era where digital presence is paramount for growth and engagement, CytoSorbents Corporation, a leading medical technology company specializing in critical care, has taken a significant leap forward by unveiling a...

In a significant development for medical device company CytoSorbents, the company recently announced securing a $20 million credit facility, providing them with a valuable injection of non-dilutive capital to accelerate...

ZoomerMedia Enhances Digital Network by Acquiring MobileSyrup.com from Blue Ant Media, Canada’s Premier Tech News SourceToronto, Canada In a strategic move to advance its digital footprint, ZoomerMedia Limited has offic...

CytoSorbents Secures Regulatory Approval for CytoSorb Blood Purification Therapy in Taiwan CytoSorbents Corporation, a critical care immunotherapy leader specializing in blood purification, has announced that its flagsh...

This innovative technology, designed and patented by CytoSorbents Corporation, focuses on reducing the risk factors linked with organ failure and dysfunction following a heart transplant. These risk factors include a hi...

Septic shock remains a significant healthcare burden worldwide, with high mortality rates and limited treatment options. The recent advancements in hemoadsorption therapy using the CytoSorb® extracorporeal hemoperfusion...

CytoSorbents Strengthens Balance Sheet with $10.3M Registered Direct Offering. Insiders invest $435,000 Despite Long-Term BorrowingsCytoSorbents Corporation, a leading critical care immunotherapy company specializing in...